Back to Search Start Over

Systolic-dicrotic notch pressure difference can identify tachycardic patients with septic shock at risk of cardiovascular decompensation following pharmacological heart rate reduction.

Authors :
Morelli A
Romano SM
Sanfilippo F
Santonocito C
Frati G
Chiostri M
Agrò FE
Ertmer C
Rehberg SW
Vieillard-Baron A
Source :
British journal of anaesthesia [Br J Anaesth] 2020 Dec; Vol. 125 (6), pp. 1018-1024. Date of Electronic Publication: 2020 Jul 18.
Publication Year :
2020

Abstract

Background: During sepsis, heart rate (HR) reduction could be a therapeutic target, but identification of responders (non-compensatory tachycardia) and non-responders (compensatory for 'fixed' stroke volume [SV]) is challenging. We tested the ability of the difference between systolic and dicrotic pressure (SDP <subscript>difference</subscript> ), which reflects the coupling between myocardial contractility and a given afterload, in discriminating the origin of tachycardia.<br />Methods: In this post hoc analysis of 45 patients with septic shock with persistent tachycardia, we characterised features of haemodynamic response focusing on SDP <subscript>difference</subscript> , classifying patients according to variations in arterial dP/dt <subscript>max</subscript> after 4 h of esmolol administration to maintain HR <95 beats min <superscript>-1</superscript> . A cut-off value of 0.9 mm Hg ms <superscript>-1</superscript> was used for group allocation.<br />Results: After reducing HR, arterial dP/dt <subscript>max</subscript> remained above the cut-off in 23 patients, whereas it decreased below the cut-off in 22 patients (from 0.99 [0.37] to 0.63 [0.16] mm Hg ms <superscript>-1</superscript> ; mean [SD], P<0.001). At baseline, patients with decreased dP/dt <subscript>max</subscript> after esmolol had lower SDP <subscript>difference</subscript> than those with higher dP/dt <subscript>max</subscript> (40 [19] vs 53 [16] mm Hg, respectively; P=0.01). The SDP <subscript>difference</subscript> remained unchanged after esmolol in the higher dP/dt <subscript>max</subscript> group (49 [16] mm Hg), whereas it decreased significantly in patients with lower dP/dt <subscript>max</subscript> (29 [11] mm Hg; P<0.001). In the latter, the HR reduction resulted in a significant cardiac output reduction with unchanged SV, whereas in patients with higher dP/dt <subscript>max</subscript> SV increased (from 48 [12] to 67 [14] ml; P<0.001) with maintained cardiac output.<br />Conclusions: A decrease in SDP <subscript>difference</subscript> could discriminate between compensatory and non-compensatory tachycardia, revealing a covert loss of myocardial contractility not detected by conventional echocardiographic parameters and deteriorating after HR reduction with esmolol.<br />Clinical Trial Registration: NCT02188888.<br /> (Copyright © 2020 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1471-6771
Volume :
125
Issue :
6
Database :
MEDLINE
Journal :
British journal of anaesthesia
Publication Type :
Academic Journal
Accession number :
32690246
Full Text :
https://doi.org/10.1016/j.bja.2020.05.058